Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Mitochondria at the crossroads of health and disease
2024 Standout
2 intermediate papers

Works of Alex Senchenkov being referenced

Surgical Management of Hidradenitis Suppurativa: Outcomes of 590 Consecutive Patients
2016
Targeting Ceramide Metabolism--a Strategy for Overcoming Drug Resistance
2001

Author Peers

Author Last Decade Papers Cites
Alex Senchenkov 346 128 26 289 189 23 793
Paul O. Larson 149 165 109 192 369 20 919
A. Trotti 267 385 12 118 291 27 878
Di Zhang 193 112 98 267 149 30 788
Lynda Aoudjehane 193 60 89 290 166 35 921
K. A. Warfel 167 181 87 271 100 27 934
Li Li 94 163 68 359 278 38 797
Francesca Pirini 44 88 57 339 153 26 672
Emanuela Branchetti 171 505 21 144 117 29 980
Aswin Abraham 89 95 40 368 200 29 697
Teresa Fu 19 38 152 234 239 19 866

All Works

Loading papers...

Rankless by CCL
2026